Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Echo Therapeutics Inc (NASDAQ:ECTE)

1.62
Delayed Data
As of Jul 31
 -0.01 / -0.61%
Today’s Change
0.39
Today|||52-Week Range
3.00
+20.00%
Year-to-Date
No recent news for Echo Therapeutics Inc.

Today’s Trading

Previous close1.63
Today’s open1.58
Day’s range1.58 - 1.71
Volume12,816
Average volume (3 months)32,876
Market cap$18.0M
Dividend yield--
Data as of 3:58pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+46.78%
Earnings growth (this year)-37.10%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+107.68%
P/E ratioNM
Price/Sales289.88
Price/Book2.16

Competitors

 Today’s
change
Today’s
% change
SKBISkystar Bio-Pharmace...+0.04+2.06%
ALXAAlexza Pharmaceutica...-0.04-3.77%
AQXPAquinox Pharmaceutic...+0.20+12.20%
CAPNCapnia Inc+0.05+2.34%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$57.3K
Annual profit (last year)-$15.0M
Net profit margin-26,103.27%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Scott Wayne Hollander
Vice President-Operations &
Product Development
Thomas H. Bishop
Corporate headquarters
Iselin, New Jersey

Forecasts